Grace Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002 and is headquartered in Princeton, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Grace Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Grace Therapeutics Inc. market cap is $42.32M.
What is the 52-week high for Grace Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Grace Therapeutics Inc. 52 week high is $4.97 as of September 06, 2025.
What is the 52-week low for Grace Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Grace Therapeutics Inc. 52 week low is $1.75 as of September 06, 2025.
What is Grace Therapeutics Inc. stock price today?
Grace Therapeutics Inc. stock price today is $3.20.
What was Grace Therapeutics Inc. stock price yesterday?
Grace Therapeutics Inc. stock price yesterday was $3.06.
What is the PE ratio of Grace Therapeutics Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Grace Therapeutics Inc.’s P/E ratio is -3.71.
What is the Price-to-Book ratio of Grace Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Grace Therapeutics Inc. P/B ratio is 0.6659.
What is the 50-day moving average of Grace Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Grace Therapeutics Inc. 50-day moving average is $3.12.
